Showing results (171-180 of 7,627) with videos related to
Sort By:
Pageof 763
American Journal of Hematology|March 29, 2011
Delayed G-CSF stimulation after PBSCT does not seem to modify the biological parameters of bone marrow recoveryJean-Christophe Ianotto, Adrian Tempescul, Pascal Delepine, et al.American Journal of Hematology|March 29, 2011
Hospital volume, hospital teaching status, patient socioeconomic status, and outcomes in patients hospitalized with sickle cell diseaseTimothy L McCavit, Hua Lin, Song Zhang, et al.American Journal of Hematology|May 4, 2011
Nonadherence to imatinib adversely affects event free survival in chronic phase chronic myeloid leukemiaPrasanth Ganesan, Tenali Gnana Sagar, Biswajit Dubashi, et al.American Journal of Hematology|March 1, 1990
Immunogenetic analysis of bone marrow aspirates in patients with non-Hodgkin lymphomasD J Ellison, E Hu, D Zovich, et al.American Journal of Hematology|April 28, 2011
Isolated del(5q) in myeloid malignancies: clinicopathologic and molecular features in 143 consecutive patientsMrinal M Patnaik, Terra L Lasho, Christy M Finke, et al.American Journal of Hematology|April 28, 2011
Clinical effect of reduced-intensity conditioning regimen containing antithymocyte globulin for hematopoietic cell transplantation from unrelated-donorsKyoo-Hyung Lee, Seong-Jun Choi, Je-Hwan Lee, et al.American Journal of Hematology|April 28, 2011
Predicted costs of iron-chelators in myelodysplastic syndromes: a 10-year analysis based on actual prevalence and red cell transfusion ratesSenthilkumar Durairaj, Stephen Chew, Ann Hyslop, et al.American Journal of Hematology|April 28, 2011
Plasma glial fibrillary acidic protein levels in children with sickle cell diseaseWilliam J Savage, Emily Barron-Casella, Zongming Fu, et al.American Journal of Hematology|November 1, 2011
The use of selective immunosuppressive therapy on myelodysplastic syndromes in targeted populations results in good response rates and avoids treatment-related disease progressionLi Xiao, Zhu Qi, Chen Qiusheng, et al.American Journal of Hematology|November 29, 2011
Monosomal karyotype in acute myeloid leukemia predicts adverse treatment outcome and associates with high functional multidrug resistance activityHee Kyung Ahn, Jun Ho Jang, Kihyun Kim, et al.Pageof 763